biomarker discovery
Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant
University researchers will use the firm's platform to analyze microbiome biomarkers to develop a noninvasive early detection method for hepatocellular carcinoma.
Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D
Data analysis firm Syntegra will work with NashBio to produce and validate synthetic data from the BioVU biobank, starting with type 2 diabetes.
Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC
As part of its Biomarker Assist program, Amgen will cover the cost of NeoGenomics' KRAS tests for advanced or metastatic NSCLC patients regardless of their insurance status.